(Admir Buljubasic/Pool via AP)TORONTO, ONT – Canada on Monday suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots. Health Canada said it has not received any reports of blood clots in Canada, and the department’s chief medical adviser, Dr. Supriya Sharma, said she still believes the vaccine’s benefits outweigh the risks. Last week, the department changed its label on the vaccine to warn about the rare risk of blood clots. Canada is expected to receive 1.5 million doses of AstraZeneca from the U.S. on Wednesday. Canada has placed bigger bets on Pfizer and Moderna, ordering up to 76 million doses of Pfizer and up to 44 million of Moderna, compared with up to 20 million of AstraZeneca.